Enantiomers, or molecule pairs that are mirror images of each other, make up more than half of FDA-approved drugs in use ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Non-Commercial (NC): Only non-commercial uses of the work are permitted. No ...

Abstract: Drug function study is vital in current drug discovery, design, and development. Determining the drug functions of a novel drug is time-consuming, complicated, expensive, and requires many ...

In the complex and costly world of pharmaceutical development, the process of drug discovery remains one of the most significant bottlenecks, with scientists often describing compound optimization as ...

"Today's approval is a transformative moment for patients, clinicians, and the field," said Dr. Howard Fillit, Co-Founder and Chief Science Officer of the Alzheimer’s Drug Discovery Foundation (ADDF).

The work in this collection highlights the accomplishments of China's medicinal chemistry community and we encourage Chinese researchers to submit their original findings, drug annotations, and ...

In fact, he complained bitterly before taking office about the pharmaceutical industry’s powerful lobbyists, and said drug companies were “getting away with murder.” In his first term ...

Cadence Design Systems, Inc. has officially unveiled its new Millennium M2000 Supercomputer at CadenceLIVE Silicon Valley 2025, a significant step in revolutionizing AI-accelerated simulation for ...

ALBANY — Gov. Kathy Hochul and district attorneys got the partial rollback they wanted on a key element of courtroom trials, known as “criminal discovery.” Now, defense attorneys are bracing ...

The Food and Drug Administration has been meeting with OpenAI to discuss the agency’s use of AI, according to sources with knowledge of the meetings. The meetings appear to be part of a broader ...

A new medication that combines an already approved drug with a new unapproved one has been shown to cut the level of LDL, or “bad” cholestero l, when statins aren’t helping enough.

One of the biggest bottlenecks in the preclinical drug discovery process is the enormous amount of time and money needed to balance a drug's potency with the critical properties of absorption ...